Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Combined de‐repression of chemoresistance associated mitogen‐activated protein kinase 14 and activating transcription factor 2 by loss of microrna‐622 in hepatocellular carcinoma (2021) Fritz V, Malek L, Gaza A, Wormser L, Appel M, Kremer A, Thasler WE, et al. Journal article Precision of handheld multispectral optoacoustic tomography for muscle imaging (2021) Wagner A, Danko V, Federle A, Klett D, Simon D, Heiß R, Jüngert JM, et al. Journal article Involvement of Neuro-Immune Interactions in Pruritus With Special Focus on Receptor Expressions (2021) Ruppenstein A, Limberg MM, Loser K, Kremer A, Homey B, Raap U Journal article, Review article Food Intolerance of Unknown Origin: Caused by Mucosal Inflammation? A Pilot Study (2021) Dieterich W, Tietz E, Kohl M, Konturek PC, Rath T, Neurath M, Zopf Y Journal article CCR8 Signaling via CCL1 Regulates Responses of Intestinal IFN-γ Producing Innate Lymphoid CelIs and Protects From Experimental Colitis (2021) Kang L, Schmalzl A, Leupold T, Gonzalez-Acera M, Atreya R, Neurath M, Becker C, Wirtz S Journal article THE AMOUNT OF LIVER TISSUE IS ESSENTIAL FOR ACCURATE HISTOLOGICAL STAGING IN PATIENTS WITH AUTOIMMUNE HEPATITIS (2021) Vetter M, Kremer A, Agaimy A, Konturek PC, Pfeifer L, Neurath M, Zopf S, Siebler J Journal article The JAK1/3 Inhibitor to Tofacitinib Suppresses T Cell Homing and Activation in Chronic Intestinal Inflammation (2021) Gerlach K, Lechner K, Popp V, Offensperger L, Zundler S, Wiendl M, Becker E, et al. Journal article Efficacy, safety and quality of life (QoL) with Lanreotide Autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumors (NETs): CLARINET FORTE study results (2021) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Thanh TXM, et al. Conference contribution Advanced small intestine well-differentiated neuroendocrine tumors (WD-SiNET): A survey of practice on 3rd line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Conference contribution The use of deep learning models to predict progression-free survival in patients with neuroendocrine tumors: Results from phase 3 of the RAISE project (2021) Pavel ME, Dromain C, Ronot M, Schaefer N, Mandair D, Gueguen D, Elvira D, et al. Conference contribution